Jonah Shacknai: Difference between revisions
Content deleted Content added
Undid revision 906542201 by Praxidicae (talk) He is notable, and I am adding some more information to hopefully convince that Shacknai does deserve his own Wiki article. Tags: Removed redirect Visual edit |
Added sources, including books, that include Shacknai |
||
| Line 6: | Line 6: | ||
== Government == |
== Government == |
||
From 1977 until the end of 1982 Shacknai worked as the Chief Aide to the committee on health policy in the US House of Representatives. He also served on the Commission on the Federal Drug Approval Process and the National Council on Drugs.<ref name=":2" /> |
From 1977 until the end of 1982 Shacknai worked as the Chief Aide to the committee on health policy in the US House of Representatives. As such, he wrote key legislation on health care, environmental and consumer protection, and science policy.<ref>{{Cite journal|last=Shacknai|first=Jonah|date=1985|title=Trade Secrets under the Drug Price Competition and Patent Term Restoration Act of 1984|url=https://heinonline.org/HOL/Page?handle=hein.journals/foodlj40&id=335&div=&collection=|journal=Food, Drug, Cosmetic Law Journal|volume=40|pages=329}}</ref> He also served on the Commission on the Federal Drug Approval Process and the National Council on Drugs.<ref name=":2" /><ref>{{Cite book|title=Hoover's Handbook of Emerging Companies 2004|last=Hoover's, Incorporated|first=|publisher=Hoover's, Incorporated|year=2004|isbn=9781573110914|location=|pages=239, 502}}</ref><ref>{{Cite book|title=The role of R.& D. in improving the quality in urban life:|last=United States. Congress. House. Committee on Science and Technology. Subcommittee on Domestic and International Scientific Planning, Analysis, and Cooperation|first=|publisher=U.S. Govt. Print. Office|year=1978|isbn=|location=|pages=429}}</ref> |
||
Shacknai served on two federal cabinet-appointed positions; he was a member of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council and on the US-Israel Science and Technology Commission.<ref name=":2" /><ref>{{Cite book|title=CQ Congressional Quarterly Weekly Report|last=|first=|publisher=Congressional Quarterly, Incorporated|year=1986|isbn=|volume=44|location=|pages=2099}}</ref><ref>{{Cite book|title=Robotics: Hearings Before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, Second Session|last=United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight|first=|publisher=U.S. Government Printing Office|year=1982|isbn=|location=|pages=1, 112}}</ref> |
|||
== Law firm == |
|||
He was a senior partner at the law firm Royer, Shacknai and Mehle from 1982 until 1988. The firm represented multinational pharmaceutical companies, medical device makers and four major industry trade associations.<ref name=":2" /> |
|||
== Medicis Pharmaceutical Corporation == |
== Medicis Pharmaceutical Corporation == |
||
Shacknai founded Medicis Pharmaceuticals in 1988.<ref>{{Cite web|url=https://www.twst.com/interview/jonah-shacknai-medicis-pharmaceutical-corporation-mrx|title=Jonah Shacknai - Medicis Pharmaceutical Corporation (mrx)|date=2001-01-10|website=The Wall Street Transcript|language=en-US|access-date=2019-07-16}}</ref> In 2012 he left his positions as CEO and chairman when [[Bausch Health|Valeant Pharmaceuticals]] purchased Medicis for $2.6 billion.<ref>{{Cite web|url=https://www.bizjournals.com/phoenix/news/2012/12/11/valeant-medicis-complete-26b.html|title=Valeant, Medicis complete $2.6B merger; Shacknai out|last=Gonzales|first=Angela|date=11 December 2012|website=www.bizjournals.com|archive-url=|archive-date=|dead-url=|access-date=2019-07-16}}</ref> |
Shacknai founded Medicis Pharmaceuticals in 1988.<ref>{{Cite web|url=https://www.twst.com/interview/jonah-shacknai-medicis-pharmaceutical-corporation-mrx|title=Jonah Shacknai - Medicis Pharmaceutical Corporation (mrx)|date=2001-01-10|website=The Wall Street Transcript|language=en-US|access-date=2019-07-16}}</ref> In 2012 he left his positions as CEO and chairman when [[Bausch Health|Valeant Pharmaceuticals]] purchased Medicis for $2.6 billion.<ref>{{Cite web|url=https://www.bizjournals.com/phoenix/news/2012/12/11/valeant-medicis-complete-26b.html|title=Valeant, Medicis complete $2.6B merger; Shacknai out|last=Gonzales|first=Angela|date=11 December 2012|website=www.bizjournals.com|archive-url=|archive-date=|dead-url=|access-date=2019-07-16}}</ref> |
||
== Boards == |
|||
He serves as executive Chairman of DermaForce Partners. He held an executive position at Key Pharmaceuticals Inc and served on the Listed Company Advisory Committee to the New York Stock Exchange (LCAC)<ref name=":2" /> |
|||
== Personal life == |
== Personal life == |
||
Revision as of 07:22, 17 July 2019
Jonah Shacknai (born 1957)[1] is a chairman at Illustris Pharmaceuticals[2] and was the founder, chairman and CEO of Medicis Pharmaceutical Corporation.[1] He also served as Chief Aide to the US House of Representative's committee for health policy.[3]
Education
Shacknai earned his BS from Colgate University[3] and his JD from Georgetown University Law Center. [2][4][5]
Government
From 1977 until the end of 1982 Shacknai worked as the Chief Aide to the committee on health policy in the US House of Representatives. As such, he wrote key legislation on health care, environmental and consumer protection, and science policy.[6] He also served on the Commission on the Federal Drug Approval Process and the National Council on Drugs.[3][7][8]
Shacknai served on two federal cabinet-appointed positions; he was a member of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council and on the US-Israel Science and Technology Commission.[3][9][10]
Law firm
He was a senior partner at the law firm Royer, Shacknai and Mehle from 1982 until 1988. The firm represented multinational pharmaceutical companies, medical device makers and four major industry trade associations.[3]
Medicis Pharmaceutical Corporation
Shacknai founded Medicis Pharmaceuticals in 1988.[11] In 2012 he left his positions as CEO and chairman when Valeant Pharmaceuticals purchased Medicis for $2.6 billion.[12]
Boards
He serves as executive Chairman of DermaForce Partners. He held an executive position at Key Pharmaceuticals Inc and served on the Listed Company Advisory Committee to the New York Stock Exchange (LCAC)[3]
Personal life
Shacknai is remarried, and is the father of five children, including Max, who died in an accident in July 2011.[13]
References
- ^ a b Rosen, Jamie. "Medicis Man". W Magazine. Retrieved 2019-07-16.
- ^ a b MarketScreener. "Jonah Shacknai, PhD - Biography". www.marketscreener.com. Retrieved 2019-07-16.
- ^ a b c d e f "Shacknai, Jonah". The Wall Street Transcript. 2015-09-10. Retrieved 2019-07-16.
- ^ "Leadership". Illustris. Retrieved 2019-07-16.
- ^ "Jonah Shacknai, Medicis Pharmaceutical Corp: Profile and Biography". Bloomberg.com. Retrieved 2019-07-16.
- ^ Shacknai, Jonah (1985). "Trade Secrets under the Drug Price Competition and Patent Term Restoration Act of 1984". Food, Drug, Cosmetic Law Journal. 40: 329.
- ^ Hoover's, Incorporated (2004). Hoover's Handbook of Emerging Companies 2004. Hoover's, Incorporated. pp. 239, 502. ISBN 9781573110914.
- ^ United States. Congress. House. Committee on Science and Technology. Subcommittee on Domestic and International Scientific Planning, Analysis, and Cooperation (1978). The role of R.& D. in improving the quality in urban life:. U.S. Govt. Print. Office. p. 429.
{{cite book}}: CS1 maint: multiple names: authors list (link) - ^ CQ Congressional Quarterly Weekly Report. Vol. 44. Congressional Quarterly, Incorporated. 1986. p. 2099.
- ^ United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight (1982). Robotics: Hearings Before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, Second Session. U.S. Government Printing Office. pp. 1, 112.
- ^ "Jonah Shacknai - Medicis Pharmaceutical Corporation (mrx)". The Wall Street Transcript. 2001-01-10. Retrieved 2019-07-16.
- ^ Gonzales, Angela (11 December 2012). "Valeant, Medicis complete $2.6B merger; Shacknai out". www.bizjournals.com. Retrieved 2019-07-16.
{{cite web}}: Cite has empty unknown parameter:|dead-url=(help) - ^ "Parents of 6-year-old boy initially believed Rebecca Zahau saved their injured son". San Diego Union-Tribune. 2018-03-08. Retrieved 2019-07-16.